FN2 Earnings Intelligence

TG Therapeutics, Inc. income statement (quarterly)

TG Therapeutics, Inc. (TGTX) Income Statement (quarterly) derived from persisted SEC financial facts.

Income Statement

USD in millions, except per-share values and percentages.

Metric 3/31/20256/30/20259/30/20253/31/20269/30/202612/30/2026 est.3/30/2027 est.
Revenue $120.9$141.1$161.7$204.9$259.9$290.2$293.9
Gross Profit $105.3$122.2$133.6$171.4$217.9--
EBITDA $8.6--$34.8---
Net Income $5.1$28.2$390.9$19.8$55.5--
Diluted EPS $0.03$0.17$2.43$0.12$0.35$0.52$0.64

Get the TGTX recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.